Six years of continuous mechanical circulatory support following chronic graft failure. Issue 1 (18th October 2022) - Ghoneim, Mohamed
Abstract : Re‐transplantation is the preferred treatment for patients with chronic heart transplant failure. If re‐transplantation is not a viable option due to the patient's comorbidities, left ventricle assist device can be used as the destination treatment. An interdisciplinary approach with thorough follow‐up can help in the early detection and treatment of complications associated with LVAD.